Patient-reported outcomes in acute graft-versus-host disease: optimizing patient care and clinical trial endpoints.

Bone Marrow Transplantation
Sagar S PatelBetty K Hamilton

Abstract

Patient-reported outcomes (PROs) refer to patient perceived and reported health-related quality of life (HRQOL), functional status, and symptom burden. PROs have become an important measure in oncologic care to identify the impact of the disease and its treatment on a patient's health status. Hematopoietic cell transplantation (HCT) is an aggressive and potentially curative therapy for patients with high-risk hematologic malignancies. A common complication of HCT is graft-versus-host disease (GVHD), which can be a significant contributor to morbidity and mortality, as well as a wide spectrum of physical and psychosocial effects. Quality of life and symptom burden have been shown to be important measures in the study of posttransplant complications, including chronic GVHD. We review the need for a novel tool in acute GVHD to capture disease symptoms and HRQOL to better understand patient symptoms, disease trajectory and outcome.

References

Feb 12, 2002·European Journal of Internal Medicine·Marielle G.J. Hendriks, Harry C. Schouten
Sep 18, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie k LeeJoseph H Antin
Dec 17, 2002·JAMA : the Journal of the American Medical Association·Symone B DetmarNeil K Aaronson
Aug 22, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel J WeisdorfNancy A Kernan
Nov 25, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Catherine AcquadroUNKNOWN PRO Harmonization Group
Jun 2, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Elizabeth M AltmaierRoger Gingrich
Jul 5, 2006·Bone Marrow Transplantation·S J LeeJ H Antin
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephanie J Lee, Loretta A Williams
Jun 22, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Christine Bower BacaAnne T Berg
Nov 27, 2010·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Michael BrundageDeb Feldman-Stewart
Feb 26, 2011·Journal of Pharmacology & Pharmacotherapeutics·Kenneth F SchulzDavid Moher
Oct 7, 2011·Clinical Pharmacology and Therapeutics·N E RothrockD Cella
Dec 21, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·William A WoodBryce B Reeve
Feb 28, 2013·JAMA : the Journal of the American Medical Association·Melanie CalvertUNKNOWN CONSORT PRO Group
May 13, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Areej El-JawahriYi-Bin Chen
Jun 11, 2014·Blood·Shernan G HoltanDaniel J Weisdorf
Jan 15, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Margaret L MacMillanDaniel J Weisdorf
Dec 22, 2015·The Lancet. Haematology·John E LevineUNKNOWN Blood and Marrow Transplant Clinical Trials Network
Jan 30, 2016·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Ines RombachÓrlaith Burke
Jun 7, 2017·JAMA : the Journal of the American Medical Association·Ethan BaschDeborah Schrag
Mar 17, 2018·Blood·Hannah Major-MonfriedJohn E Levine
Jun 7, 2018·Bone Marrow Transplantation·Helene M SchoemansUNKNOWN EBMT (European Society for Blood and Marrow Transplantation) Transplant Complications Working Party and the “EBMT−NIH (Natio
Jun 16, 2018·Haematologica·Helene M SchoemansUNKNOWN EBMT Transplantation Complications Working party

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

CONSORT
PRO

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.